A. Tikoo

发表

p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

K. Arden, J. Heath, J. Heath, 2000, Gene.

Reconstitution of stratified murine and human oesophageal epithelia in an in vivo transplant culture system

W. Phillips, S. Nandurkar, Robert J. S. Thomas, 2008, Scandinavian journal of gastroenterology.

Tissue distribution of Diablo/Smac revealed by monoclonal antibodies

C. Day, L. O'Reilly, A. Verhagen, 2002, Cell Death and Differentiation.

Localization of the ezrin binding epitope for advanced glycation endproducts.

M. Cooper, L. Bach, A. Tikoo, 2008, The international journal of biochemistry & cell biology.

Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.

M. Cooper, L. Bach, A. Tikoo, 2006, Journal of the American Society of Nephrology : JASN.

Effects of Advanced Glycation End Products on Ezrin‐Dependent Functions in LLC‐PK1 Proximal Tubule Cells

M. Cooper, L. Bach, A. Tikoo, 2005, Annals of the New York Academy of Sciences.

The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors.

H. Maruta, A. Tikoo, D. Z. Wang, 1997, Cancer research.

Physiological Levels of Pik3ca H1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors

M. Shackleton, W. Phillips, P. Waring, 2012, PloS one.

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).

J. Gusella, V. Ramesh, H. Maruta, 1994, The Journal of biological chemistry.

Low‐dose prednisone and immunoglobulin G treatment for woman at risk for neonatal alloimmune thrombocytopenia and T helper 1 immunity

A. Gilman‐Sachs, A. Tikoo, J. Kwak‐Kim, 2017, American journal of reproductive immunology.

ASSOCIATION OF PREVALENCE OF COMPLICATIONS WITH DURATION OF DIABETES IN TYPE 2 DIABETICS OF JAMMU REGION

S. Kaur, A. Tikoo, S. Chander, 2018 .

Expression and role of a2 vacuolar‐ATPase (a2V) in trafficking of human neutrophil granules and exocytosis

A. Gilman‐Sachs, Leyla Akman-Anderson, M. Jaiswal, 2015, Journal of leukocyte biology.

A Clue to the Therapy of Neurofibromatosis Type 2: NF2/Merlin Is a PAK1 Inhibitor

J. Testa, M. Giovannini, G. Xiao, 2004, Cancer journal.

Enteropathogenicity and antimicrobial susceptibility of new Escherichia spp.

G. Nath, A. Chaudhury, A. Tikoo, 1999, Journal of diarrhoeal diseases research.

Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.

S. Lo, H. Cutler, L. B. Chen, 1999, The cancer journal from Scientific American.

Development of an improved synthetic medium for a better production of the new cholera toxin and its immunological relationship with the toxin produced by Vibrio cholerae O139 strains.

D. Singh, A. Tikoo, S. Sanyal, 1996, FEMS immunology and medical microbiology.

The Anti‐RAS Cancer Drug MKT‐077 Is an F‐Actin Cross‐Linker

T. Shishido, H. Maruta, A. Tikoo, 1999, Annals of the New York Academy of Sciences.

Cytoskeletal Tumor Suppressors That Block Oncogenic RAS Signaling

H. Maruta, A. Tikoo, Hong He, 1999, Annals of the New York Academy of Sciences.

An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.

Kylie L. Gorringe, J. Christensen, R. Pearson, 2012, The Journal of clinical investigation.

HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins*

R. Moritz, D. Vaux, P. Ekert, 2002, The Journal of Biological Chemistry.

Production of the new cholera toxin by environmental isolates of Vibrio cholerae non-O1.

D. Singh, A. Tikoo, S. Sanyal, 1996, Journal of medical microbiology.

Influence of animal passage on haemolysin and enterotoxin production in Vibrio cholerae O1 biotype El Tor strains.

D. Singh, A. Tikoo, S. Sanyal, 1994, Journal of medical microbiology.

The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.

H. Maruta, A. Tikoo, M. Fridman, 1994, The Journal of biological chemistry.

Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.

L. Connolly, L. Ye, Y. Hirokawa, 2000, Cancer journal.

MICROALBUMINURIA AS A NOVEL MARKER OF CKD IN RELATION WITH COMPLICATIONS OF DIABETES

S. Kaur, A. Tikoo, S. Chander, 2020 .

Localization of the Ezrin Binding Epitope for Glycated Proteins

M. Cooper, L. Bach, A. Tikoo, 2005, Annals of the New York Academy of Sciences.

Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H+)-ATPase Inhibitors †

B. Kolli, A. Gilman‐Sachs, A. Kulshrestha, 2017, Molecules.

Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.

A. Scott, D. N. Watkins, W. Phillips, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Hematological lesions in rat following heavy alcohol ingestion.

A. Tikoo, K. C. Kanwar, 1992, Journal of Environmental Pathology And Toxicology.

G proteins, phosphoinositides, and actin‐cytoskeleton in the control of cancer growth

H. Maruta, A. Tikoo, Hong He, 1999, Microscopy research and technique.